lynestrenol has been researched along with Hormone-Dependent Neoplasms in 1 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Excerpt | Relevance | Reference |
---|---|---|
"Intratumoral activity of the enzyme 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) was measured in 55 patients with breast cancer (17 pre- and 38 post-menopausal) before and/or after 8 days of a progestin treatment (lynestrenol 10 mg/day)." | 3.67 | [Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers]. ( Allali, F; Debertrand, P; Diebold, N; Durand, JC; Fournier, S; Kuttenn, F; Martin, PM; Mauvais-Jarvis, P; Sterkers, N, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fournier, S | 1 |
Allali, F | 1 |
Durand, JC | 1 |
Sterkers, N | 1 |
Debertrand, P | 1 |
Diebold, N | 1 |
Martin, PM | 1 |
Kuttenn, F | 1 |
Mauvais-Jarvis, P | 1 |
1 other study available for lynestrenol and Hormone-Dependent Neoplasms
Article | Year |
---|---|
[Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers].
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Aged; Breast; Breast Neoplasms; Estradiol; Evaluation Studi | 1985 |